AbbVie partners with Chicago Cubs to fund cancer research; ‘We aim to create greater awareness for cancer advocacy'
Though there is an emphasis on blood cancers, Andy Souers, AbbVie's vice president heading oncology discovery research, said the scientists are also trying to find treatments that work for ovarian, lung and colorectal cancers, among others.
Working meticulously over sometimes long periods of time, looking at human cells and the molecules within them, Souers said the scientists look for ways to kill the malignant cells to improve a patient's condition.
'We take white cells out of the body to help find ways of curation,' Souers said. 'We look for ways we can just kill the tumor cells.'
As Souers and his colleagues in AbbVie's labs work to find more solutions to treat cancer, the company is increasing its awareness campaign for cancer advocacy, including a partnership with the Chicago Cubs announced Friday, which could put thousands of dollars toward treating cancer.
Dubbed 'Striking Out Cancer,' for every strikeout a Cub pitcher throws during the 2025 home season starting last Friday, AbbVie will donate $233 to Cub Charities, according to an AbbVie press release. The $233 amount is in honor of the 233 Americans diagnosed with cancer every hour.
'Together with our hometown partner, the Chicago Cubs, we aim to create greater awareness for cancer advocacy and to make a remarkable impact for those living with cancer worldwide,' Tracie Haas, AbbVie's senior vice president for corporate affairs, said in the release.
In the Cubs' three games over the weekend. the team's pitchers struck out 18 batters netting nearly $5,000 to fight cancer. With 63 home games left this season, the donation could approach more than $100,000.
While the Cub pitchers are doing their part, AbbVie's scientists continue to look for more ways to snuff out cancerous cells. Other people at the company are doing their part, getting the medicine to the patients who need it.
Lung cancer is a serious concern and receiving a lot of emphasis from AbbVie because, Souers said, it is one of the deadliest. The five-year survival rate is less than 10%, creating an urgency in the lab.
'It's a small cell and that makes it very, very hard,' Souers said. 'Our goal is to dose the patient. Once we have something which works, we go to the next generation of the medicine.'
In the labs, people and machines are working together to test and retest potential medicines until they work. Emily Faivre, a senior principal research scientist working in the labs devoted to finding effective medicine to treat cancer, said the testing is rigorous before the approval process even starts.
Holding a 2½-inch-by-four-inch specimen container with 384 wells — it's like a honeycomb from a beehive — Faivre said each well receives a drop of material for testing through laboratory equipment.
'It reads enzyme activity,' Faivre said. 'The molecules are very small. We need to know how many we need to kill a cancer cell.'
Once the medicine is created and completes the regulatory process, with the U.S. Food and Drug Administration as well as similar agencies in other countries around the world, Brian Anderson deals with the logistics of getting it to other nations.
Anderson, AbbVie's vice president of product development for science and technology, said the company has established two distinct supply chains. If there is a problem with one, the other can pick up the slack while the issue is resolved. It assures a patient will get their life-saving drug.
'We supply these medicines to 175 countries around the world,' Anderson said. 'We are doing this on a fairly large scale. Thousands of people need this product.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
an hour ago
- New York Post
I went blind after doing cartwheels — here's what I learned after losing my vision
A woman who lost her ability to see after a joyful romp on the beach is opening up about the frightening ordeal. Deborah Cobb was 19 years old when she broke out in a series of cartwheels — only to come up without her vision. Now 42, Cobb has said that she has the ocular health of an 80-year-old and anticipates she will soon return to blindness due to early-onset macular degeneration. Advertisement 4 Seemingly harmless horseplay caused temporary blindness and chronic illness for one 19-year-old woman. Mikhail Ulyannikov – In a new interview with Newsweek, Cobb said she was with her friends when she decided to challenge herself to do as many cartwheels in a row as she could 'just for fun.' 'I started doing them and got to 13 and fell over super dizzy. My eyes were kind of spinning, so it took a moment to realize that my eyes weren't focusing,' she recalled. Advertisement 'Looking at her face, it was a giant orange blur,' Cobb continued, referring to a friend who witnessed the shocking moments. 'My eyes wouldn't fully focus. There was no pain, and my peripheral vision was fine, but everything I looked directly at was blocked by an orange blur.' Cobb's harrowing story went viral in a recent post on Instagram, where she detailed the mysterious medical phenomenon that doctors first thought was a sign of leukemia and even AIDS. 'I had neither. Just weak blood vessels in my eyes that is apparently a genetic trait as I later learned,' she wrote of her condition, called macular degeneration. 4 Deborah Cobb, now 42, shared details of her macular degeneration diagnosis on Instagram. deborahcobb_ihp/Instagram Advertisement Cobb explained in the viral video post that her gymnastic stunts had caused internal hemorrhages in a part of her eye called the macula, an area at the center of the retina that is responsible for sharp, focused vision. Macular degeneration is the leading cause of vision loss, affecting more than 200,000 Americans every year, usually brought on by old age and other factors, including genetics and cardiovascular disease. The condition causes blurred and distorted vision, dark spots changes in color perception. She was deemed 'legally blind' for three months after the initial incident, and did not regain full vision for another three months thereafter. 4 Macular degeneration, usually only seen in the elderly, affects the eye's ability to bring sight into sharp focus. mihai – Advertisement Cobb's life came to a halt during that time. As a result of the injury, she was forced to quit massage school. She couldn't drive, watch TV or even look at herself in the mirror. Though she was eventually able to return to school and later earned her license in massage therapy, she still lives in fear of losing her vision again. 'I can't do anything upside down or anything that causes too much blood to rush to my head. It happened once from doing push-ups, so I have to limit myself physically,' Cobb wrote. 4 Due to her eye condition, Cobb can no longer engage in physically exhaustive activities without risk of losing her vision again. deborahcobb_ihp/Instagram The experience inspired Cobb to dedicate her career to integrative medicine, and she now works with clients who suffer from anxiety and nervous system dysregulation. Cobb has also said that losing her vision gave her a positive new outlook on life, saying she's so thankful for the lessons in empathy and 'to not take the simple things for granted.' 'I could live in fear because of it, or I could be filled with gratitude because of it,' Cobb concluded in the thoughtful post. 'I choose gratitude, because who wants to live in fear?!'
Boston Globe
an hour ago
- Boston Globe
Trump's tariffs are making money. That may make them hard to quit.
Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up 'The good news is that Tariffs are bringing Billions of Dollars into the USA!' Trump said on social media shortly after a weak jobs report showed signs of strain in the labor market. Advertisement Over time, analysts expect that the tariffs, if left in place, could be worth more than $2 trillion in additional revenue over the next decade. Economists overwhelmingly hope that doesn't happen and the United States abandons the new trade barriers. But some acknowledge that such a substantial stream of revenue could end up being hard to quit. Advertisement 'I think this is addictive,' said Joao Gomes, an economist at the University of Pennsylvania's Wharton School. 'I think a source of revenue is very hard to turn away from when the debt and deficit are what they are.' The Port of Baltimore on June 30, 2025. ALYSSA SCHUKAR/NYT Trump has long fantasized about replacing taxes on income with tariffs. He often refers fondly to American fiscal policy in the late 19th century, when there was no income tax and the government relied on tariffs, citing that as a model for the future. And while income and payroll taxes remain by far the most important sources of government revenue, the combination of Trump's tariffs and the latest Republican tax cut does, on the margin, move the United States away from taxing earnings and toward taxing goods. Such a shift is expected to be regressive, meaning that rich Americans will fare better than poorer Americans under the change. That's because cutting taxes on income does, in general, provide the biggest benefit to richer Americans who earn the most income. The recent Republican cut to income taxes and the social safety net is perhaps the most regressive piece of major legislation in decades. Placing new taxes on imported products, however, is expected to raise the cost of everyday goods. Lower-income Americans spend more of their earnings on those more expensive goods, meaning the tariffs amount to a larger tax increase for them compared with richer Americans. Tariffs have begun to bleed into consumer prices, with many companies saying they will have to start raising prices as a result of added costs. And analysts expect the tariffs to weigh on the performance of the economy overall, which in turn could reduce the amount of traditional income tax revenue the government collects every year. Advertisement 'Is there a better way to raise that amount of revenue? The economic answer is: Yes, there is a better way, there are more efficient ways,' said Ernie Tedeschi, director of economics at the Yale Budget Lab and a former Biden administration official. 'But it's really a political question.' Workers welded steel components together at a Thomas Built Buses plant in High Point, N.C., on July 21, 2025. TRAVIS DOVE/NYT Tedeschi said that future leaders in Washington, whether Republican or Democrat, may be hesitant to roll back the tariffs if that would mean a further addition to the federal debt load, which is already raising alarms on Wall Street. And replacing the tariff revenue with another type of tax increase would require Congress to act, while the tariffs would be a legacy decision made by a previous president. 'Congress may not be excited about taking such a politically risky vote when they didn't have to vote on tariffs in the first place,' Tedeschi said. Some in Washington are already starting to think about how they could spend the tariff revenue. Trump recently floated the possibility of sending Americans a cash rebate for the tariffs, and Sen. Josh Hawley, R-Mo., recently introduced legislation to send $600 to many Americans. 'We have so much money coming in, we're thinking about a little rebate, but the big thing we want to do is pay down debt,' Trump said last month of the tariffs. Democrats, once they return to power, may face a similar temptation to use the tariff revenue to fund a new social program, especially if raising taxes in Congress proves as challenging as it has in the past. As it is, Democrats have been divided over tariffs. Maintaining the status quo may be an easier political option than changing trade policy. Advertisement 'That's a hefty chunk of change,' Tyson Brody, a Democratic strategist, said of the tariffs. 'The way that Democrats are starting to think about it is not that 'these will be impossible to withdraw.' It's: 'Oh, look, there's now going to be a large pot of money to use and reprogram.'' Of course, the tariffs could prove unpopular, and future elected officials may want to take steps that could lower consumer prices. At the same time, the amount of revenue the tariffs generate could decline over time if companies do, in fact, end up bringing back more of their operations to the United States, reducing the number of goods that face the import tax. 'This is clearly not an efficient way to gather revenue,' said Alex Jacquez, a former Biden official and the chief of policy and advocacy at Groundwork Collaborative, a liberal group. 'And I don't think it would be a long-term progressive priority as a way to simply collect revenue.' This article originally appeared in
Epoch Times
an hour ago
- Epoch Times
Tariff Rates ‘Pretty Much Set,' Says US Trade Representative
President Donald Trump's trade representative, Jamieson Greer, said that Americans should expect the administration's tariff levels to remain where they are, even as some trading partners look to negotiate deals past a key deadline. In an interview with CBS's 'Face the Nation with Margaret Brennan' taped on Aug. 1 but aired on Aug. 3, Greer said he does not expect trading partners that have yet to strike deals with the United States negotiate tariffs down in the coming days.
